Pioneering New Treatments for Chronic Eye Diseases
At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
Cross-linking intervention to slow or halt progressive keratoconus to help preserve patients’ vision.
Market-leading portfolio of innovative glaucoma therapies.
Developing sustained-release drug delivery platforms for retinal diseases.
We'll go first
Glaukos is committed to investing in the future of ophthalmology to transform standards of care and improve patient lives.
We continue to reinvest 29% of net sales* exclusively on research and development efforts to advance our goal of creating and delivering impactful solutions for patients.
See how our dedicated commitment to continuous innovation has resulted in an unrivaled pipeline of novel therapies.
*2019 Glaukos fiscal year
Careers at Glaukos
Help put the next wave of disruptive technologies on the market.
Work with a team that’s dedicated to making a difference in the lives of patients worldwide.
Committed to corporate giving and social responsibility
At Glaukos, we strive to continuously improve as responsible corporate citizens. We are dedicated to helping people in need, in our own community and beyond. We invest time and resources into better understanding what drives sustainability, which allows us to establish meaningful goals that propel us forward.